Petco Health and Wellness Company Inc. Class A Common Stock (WOOF)
StalwartFairStock Score: 32/100 — RISKY
Key Financials
| Current Price | $2.5 |
| Market Cap | $847M |
| P/E Ratio | 125 |
| ROE | 0.49% |
| Dividend Yield | —% |
| Sector | Consumer Cyclical |
Strengths
- Generates $130 million in annual free cash flow (15.3% yield on market cap)
- Established organization with 29,000 employees providing operational scale
Concerns
- Trades significantly above Graham Number ($2) with negative 78% margin of safety—limited downside protection
- High leverage at 2.48x debt-to-equity increases financial risk and interest expense burden
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 2.4% year-over-year signals potential demand weakness or market share loss
AI Analysis
Petco Health and Wellness Company Inc. Class A Common Stock is a micro-cap consumer cyclical company valued at $847 million. Revenue stands at $6.0 billion, though the company is currently unprofitable. From a quality standpoint, Petco shows distressed Altman Z-Score of 0.1 warrants caution and modest 1% ROE. On valuation, the stock is commanding a steep 99.7x multiple, with trades above its Graham Number with a negative 78% margin. Growth dynamics show revenue growing at -2.4% and profit growth of 81.4%. Our composite FairStock Score of 32/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $130 million in annual free cash flow (15.3% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 100x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer